Poland· PL-100494771

Gopten 2,0

A trandolapril product containing trandolaprilum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC C09AA10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedGopten 2,0ATCC09AA10REGISTER NO.PL-100494771PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Trandolapril is registered in 12 of 19 countries.

Countries holding a registration under ATC C09AA10 (trandolapril), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Trandolapril · ATC C09AA10

12 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trandolapril costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Trandolapril · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.38
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Trandolaprilum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
C09AA10
ATC class
Trandolapril
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991534479

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

282 interactions on record for trandolapril.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Trandolapril · interactions on record

282 records

  • 11 severe
  • 165 moderate
  • 17 minor
  • 16 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

73 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trandolapril in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trandolapril products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Bulgaria · Гоптен
  • Czechia · Gopten
  • Germany · Udrik
  • Denmark · Odrik, Trandolapril "viatris"
  • Estonia · Gopten
  • Spain · Gopten
  • France · Odrik, Trandolapril Biogaran
  • United Kingdom (Northern Ireland) · Trandolapril Accord-Uk, Trandolapril Generics [uk]
  • Greece · Daman, Testolan
  • Croatia · Gopten, Trandolapril Pharmas
  • Hungary · Gopten, Gopten Mite
  • Ireland · Odrik
  • Italy · Gopten, Trandolapril Mylan Generics
  • Lithuania · Gopten, Trandolapril Ingen Pharma
  • Luxembourg · Udrik
  • Latvia · Gopten
  • Portugal · Gopten, Trandolapril Generis
  • Romania · Trandolapril Arena
  • Slovenia · Gopten
  • Slovakia · Gopten, Trandolapril Ratiopharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/57587279-8bb1-4148-9f6a-18fa46157d4e
GET /v1/drugs/57587279-8bb1-4148-9f6a-18fa46157d4e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "2 mg",
  "packaging": "05909991534479 ¦ Rp ¦ 153664\n28 kaps.",
  "substance": "Trandolaprilum 2 mg",
  "common_name": "Trandolaprilum",
  "pl_product_id": "100494771",
  "pozwolenie_nr": "113/24",
  "auth_procedure": "IR",
  "authorisation_validity": "2029-03-14"
}

See everything about trandolapril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.